Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

3 Jun 2021

Abstract excerpt

Introduction: Despite the availability of new vaccines for SARS-CoV-2, there has been slow uptake and problems with supply in some parts of the world. Hence, there is still a necessity for drugs that can prevent hospitalization of patients and reduce the strain on health care systems. Drugs with sigma affinity potentially provide protection against the most severe symptoms of SARS-COV-2 and could prevent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Long-Term Effects of COVID-19
Share to Pharmacological Receptor Mechanisms and Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34236922
DOI: 10.1080/14728222.2021.1952987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagyPMID 34236922Read ↗

The Sigma-1 Receptor at the Crossroad of Proteostasis, Neurodegeneration, and AutophagySemantic proximity Read ↗

Targeting autophagy with natural products to prevent SARS-CoV-2 infectionSemantic proximity Read ↗

SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptorSemantic proximity Read ↗

The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targetsSemantic proximity Read ↗

Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular SystemSemantic proximity Read ↗

Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus InfectionSemantic proximity Read ↗

SARS-CoV-2 promote autophagy to suppress type I interferon responseSemantic proximity Read ↗

Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19Semantic proximity Read ↗

Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative DiseasesSemantic proximity Read ↗

Focusing on the Unfolded Protein Response and Autophagy Related Pathways to Reposition Common Approved Drugs against COVID-19Semantic proximity Read ↗

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read ↗

Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.